• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: PROGENIKA BIOPHARMA S.A. ID CORE XT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

PROGENIKA BIOPHARMA S.A. ID CORE XT Back to Search Results
Model Number 1020220034
Device Problem False Negative Result (1225)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Date 07/07/2020
Event Type  malfunction  
Manufacturer Narrative
The genomic dna sample was sent to grifols ih center for sequencing.Next generation sequencing interrogated rh genes proximal promoter, exons 1-10, and portions of intron 2-3.No variant was found in rh genes and sequencing provided a genotype rhce*ce, rhce*ce, but id core xt reported a genotype rhce*ce, rhce*ce.Id core xt determines c/c antigens interrogating polymorphism rhce:c.335+3039ins109 in rhce gene intron 2.The presence of the 109 bp insert is associated with c antigen.However, this sample carries a rare allele described by isbt as rhce*02.37 that provides a c+ phenotype but lacks the 109 bp insert.Id core xt reported a predicted c- phenotype, but the serology data from the user is c+, due to the presence of rare rhce*02.37 allele.Since id core xt obtained a false negative result, this is considered a discrepant result and then a malfunction.This limitation is covered by the general assay limitation described in the id core xt package insert (limitation 1).
 
Event Description
The customer reported a possible discrepancy.The serological phenotype was c+, c+ and the id core xt c-, c+.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ID CORE XT
Type of Device
ID CORE XT
Manufacturer (Section D)
PROGENIKA BIOPHARMA S.A.
ibaizabal bidea, edificio 504
parque tecnológico de bizkaia
derio, bizkaia 48160
SP  48160
Manufacturer (Section G)
PROGENIKA BIOPHARMA S.A.
ibaizabal bidea, edificio 504
parque tecnológico de bizkaia
derio, bizkaia 48160
SP   48160
Manufacturer Contact
diego tejedor
ibaizabal bidea, edificio 504
parque tecnológico de bizkaia
derio, bizkaia 48160
SP   48160
MDR Report Key10378263
MDR Text Key219199896
Report Number3006413195-2020-00013
Device Sequence Number1
Product Code PEP
Combination Product (y/n)N
Reporter Country CodeSP
PMA/PMN Number
BP170154
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type distributor,user facility
Reporter Occupation Other
Type of Report Initial
Report Date 08/07/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator No Information
Device Expiration Date10/01/2020
Device Model Number1020220034
Device Lot Number0203000020
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 07/09/2020
Initial Date FDA Received08/07/2020
Was Device Evaluated by Manufacturer? No
Date Device Manufactured07/05/2019
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? Yes
Type of Device Usage N
Removal/Correction NumberN/A
Patient Sequence Number1
-
-